Even as GSK’s RSV vaccine launch hits a serious slowdown, the British pharma has dialed up its long-term sales guidance once ...

GSK plans to buy back £2 billion (S$3.4 billion) of shares as it raised its long-term growth outlook on optimism around its ...

Tata AIG has appointed Shekhar Saurabh as its Head of Marketing. The news has been shared by Saurabh in a LinkedIn update.

Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results.

Before this role, Saurabh worked at Godrej Consumer Products, where he most recently served as the category head of marketing for home care.

GlaxoSmithKline would consider buying Pfizer’s consumer health business – but only if the price is right, according to the company's chief executive. Emma Walmsley has also been busy shaking ...

We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at ...

Consumer health care company Haleon plans to invest $54.2 million to upgrade its research and development facility in Richmond’s Northside.

Jefferies analyst Peter Welford maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

She was previously the supplier's head of commercial excellence for Europe, Middle East, Africa & Latin America ...

Pfizer Inc. is offering around 700 million shares in Haleon Plc, representing a roughly 7.7% stake in the maker of Sensodyne ...

Then the JP Morgan 43rd Annual Healthcare Conference featured M&A news from the likes of Johnson & Johnson (JNJ) and Europe’s GSK (GSK). 3 After a business update, shares of Eli Lilly (LLY) endured ...